Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)
China flag China · Delayed Price · Currency is CNY
23.09
-1.03 (-4.27%)
Oct 11, 2024, 3:04 PM CST

Tibet Cheezheng Tibetan Medicine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
12,24211,92412,06116,13313,69011,542
Upgrade
Market Cap Growth
-17.71%-1.14%-25.24%17.84%18.61%13.62%
Upgrade
Enterprise Value
11,11111,82311,87415,56412,82510,632
Upgrade
Last Close Price
23.0921.9421.9228.6123.9719.80
Upgrade
PE Ratio
20.5820.0124.6021.1531.3728.72
Upgrade
PS Ratio
5.505.835.909.119.228.23
Upgrade
PB Ratio
3.233.163.565.015.195.10
Upgrade
P/FCF Ratio
82.3826.00907.6017.74-134.6132.63
Upgrade
P/OCF Ratio
20.2717.2042.2215.5957.6028.43
Upgrade
EV/Sales Ratio
4.995.785.818.798.647.58
Upgrade
EV/EBITDA Ratio
18.7121.4919.6632.6432.3629.98
Upgrade
EV/EBIT Ratio
23.2825.2922.5037.3736.3833.37
Upgrade
EV/FCF Ratio
74.7725.78893.5517.12-126.1030.06
Upgrade
Debt / Equity Ratio
0.480.410.500.450.460.13
Upgrade
Debt / EBITDA Ratio
3.132.752.783.013.050.85
Upgrade
Debt / FCF Ratio
12.493.35127.681.60-11.870.85
Upgrade
Asset Turnover
0.340.340.360.350.400.53
Upgrade
Inventory Turnover
2.382.292.642.532.772.98
Upgrade
Quick Ratio
2.362.402.232.123.753.16
Upgrade
Current Ratio
2.492.572.352.243.893.26
Upgrade
Return on Equity (ROE)
16.23%16.18%14.21%24.28%16.51%16.92%
Upgrade
Return on Assets (ROA)
4.51%4.80%5.76%5.19%5.92%7.52%
Upgrade
Return on Capital (ROIC)
5.30%5.62%6.76%6.11%6.88%8.64%
Upgrade
Earnings Yield
4.86%4.87%3.92%4.44%2.95%3.16%
Upgrade
FCF Yield
1.21%3.85%0.11%5.64%-0.74%3.06%
Upgrade
Dividend Yield
1.99%2.19%1.78%2.06%1.42%1.77%
Upgrade
Payout Ratio
36.91%37.86%72.06%27.31%47.82%45.88%
Upgrade
Buyback Yield / Dilution
-0.03%0.05%-0.21%-0.12%-0.03%0.53%
Upgrade
Total Shareholder Return
1.96%2.24%1.57%1.95%1.39%2.30%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.